![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/BERLDRG.png)
Share the post "Beryl Drugs Shareholding pattern FY(Q3-Dec 2024-2025)"
Shareholding results offer insight into the distribution of shares among various investors, highlighting the levels of institutional and retail ownership. These results are significant for analyzing investor confidence and market sentiment. Understanding shareholding patterns can aid stakeholders in predicting how changes in ownership might affect a company’s stock performance. Beryl Drugs has released its latest shareholding reports, covering the third quarter and the fiscal year ending on (Q3-Dec 2024-2025).This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares(in %) | Current Quarter Shares(in %) | Quarter to Quarter Difference |
|---|---|---|---|---|---|
| Promoters | 13.38 Lakh | 13.38 Lakh | 26.38 | 26.38 | 0 |
| Public | 37.34 Lakh | 37.34 Lakh | 73.62 | 73.62 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| FII | 0 | 0 | 0 | 0 | 0 |
| Government | 0 | 0 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 26.38% in both September 2024- and December 2024-. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 73.62% in both September 2024- and December 2024-. This indicates that the Public control over the company did not change during this period.
Below is a detailed table showcasing the public shareholding percentage.
| Shareholder Name | Previous Quarter Quantity | Current Quarter Quantity | Previous Quarter Shares (in %) | Current Quarter Shares (in %) | Quarter-to-Quarter Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 25.52 Lakh | 26.39 Lakh | 50.32 | 52.04 | + 1.72 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 8.93 Lakh | 8.27 Lakh | 17.6 | 16.31 | -1.29 % |
| SAMIR NARENDRA GUPTA | 1.39 Lakh | 1.22 Lakh | 2.75 | 2.4 | -0.35 % |
| NARENDRAKUMAR BHAGWANDAS GUPTA | 1.24 Lakh | 1.19 Lakh | 2.44 | 2.35 | -0.09 % |
| Non Resident Indians (NRIs) | 44.57 K | 35.79 K | 0.88 | 0.71 | -0.17 % |
| Bodies Corporate | 1.54 Lakh | 1.44 Lakh | 3.04 | 2.85 | -0.19 % |
| Any Other (specify) | 90.48 K | 86.73 K | 1.78 | 1.71 | -0.07 % |
| HUF | 82.78 K | 79.03 K | 1.63 | 1.56 | -0.07 % |
Leading the way to higher stakeholding, Resident Individuals holding nominal share capital up to Rs. 2 lakhs has significantly boosted stakeholding by an impressive 1.72 %.Observations show a significant difference of -1.29 % in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s financial performance between quarters.Observations show a significant difference of -0.35 % in SAMIR NARENDRA GUPTA’s financial performance between quarters.Observations show a significant difference of -0.09 % in NARENDRAKUMAR BHAGWANDAS GUPTA’s financial performance between quarters.Observations show a significant difference of -0.17 % in Non Resident Indians (NRIs)’s financial performance between quarters.Observations show a significant difference of -0.19 % in Bodies Corporate’s financial performance between quarters.Observations show a significant difference of -0.07 % in Any Other (specify)’s financial performance between quarters.Observations show a significant difference of -0.07 % in HUF’s financial performance between quarters.
[my_shortcode1 values=”Beryl Drugs”]
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/KRITI.png)
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/DECIPHER.png)